Can we better detect suffering in unresponsive cancer patients?
NCT ID NCT05837039
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks at how healthcare providers and caregivers perceive discomfort in advanced cancer patients who have hypoactive delirium, a state where patients are unresponsive and withdrawn. Researchers will ask both groups to fill out questionnaires about the patient's discomfort levels. The goal is to see if there are differences in perception, which could help improve communication and care for patients at the end of life.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this study could help healthcare teams better understand and address discomfort in patients with hypoactive delirium, potentially improving end-of-life care.
- What could go wrong
- This is an observational study with only 100 participants, so findings may not apply to all patients. It measures perceptions, not direct patient outcomes, and may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A lifeline for cancer caregivers: can simple phone support reduce their stress?
- A digital lifeline: could Real-Time symptom tracking transform care for kids with advanced cancer?
- Can a 30-hour e-learning course equip family doctors to deliver better palliative care?
- Can a new nucleotide analogue boost cancer treatment?
- Can a cancer vaccine train the body to fight advanced tumors?
- Can two targeted drugs boost chemo against a rare Bile-Duct cancer?